Back to Results
First PageMeta Content
Microbiology / Vaccines / Vaccination / Virology / Cholera / Influenza vaccine / GeoVax / Medicine / Health / Biology


Office of the Gene Technology Regulator April 2014 Questions & Answers on licence application DIR 126 – Clinical trial of a genetically modified (GM) vaccine against cholera
Add to Reading List

Document Date: 2015-03-06 01:38:31

Open Document

File Size: 20,17 KB

Share Result on Facebook

Company

Queensland SA / PaxVax Australia Pty Ltd / /

Country

Australia / United States / Canada / /

/

IndustryTerm

therapeutic product / therapeutic products / manufactured product / /

MedicalCondition

disease / cholera / strain / live GM cholera / cholera infection / endemic disease / Unmodified cholera / /

MedicalTreatment

vaccination / /

Organization

office of the Gene Technology Regulator / Therapeutic Goods Administration / /

/

Position

Governor / /

ProvinceOrState

Washington / Victoria / /

URL

http /

SocialTag